The Moral Danger of Declaring the Pandemic Over Too Soon
By Gregg Gonsalves,
The New York Times
| 02. 17. 2022
The early 1990s were in many ways the most terrible of those first years of the AIDS epidemic in America. Research on the disease was in high gear, but drug after drug failed to stop H.I.V. Funerals for friends and family in their 20s, 30s, 40s and 50s continued unabated, and many of us at risk for getting sick had given up hope of a normal life. My friends and I, most of us just a few years out of college, lived in the moment because we weren’t sure of how much time we had left.
My cousin Carl died from AIDS-related lymphoma in July 1995. That was also the year I found out that I, too, was H.I.V. positive. I wondered if Carl’s fate might be my own soon enough.
But then we got lucky. In 1996 a new generation of treatments called protease inhibitors emerged that were able to control H.I.V. Doctors talked about the Lazarus effect: watching their patients go from near death to health. I enrolled in a clinical trial and started taking the drugs that...
Related Articles
By Matt Novak, Gizmodo | 07.23.2025
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, Kennedy recently told Tucker Carlson that AI...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...